Stimulants and the Heart - ADHD and Cardiovascular Risks
October 24, 2024
2,339
111
36
6.28%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Dr John Kruse Episodes Around October 24, 2024
See what was published immediately before and after this episode.
30:40Now PlayingStimulants and the Heart - ADHD and Cardiovascular Risks
Chapters
YouTube Description
as posted by the channelMain Chapters:
Medications, particularly stimulants, remain the best documented and most potent treatments for ADHD. But we know that many of our medications, including forms of amphetamine (Adderall, Vyvanse), methylphenidate (Ritalin, Concerta), atomoxetine (Strattera), and bupropion (Wellbutrin) increase blood pressure and heart rate slightly in the first weeks and months of treatment.
A 2022 meta-analysis of almost four million patients failed to find negative cardiac health impacts from ADHD medications. But a more recent, longer term study (2-7 years), comparing those with ADHD and cardiovascular disease to those with ADHD but no cardiovascular disease, found that ADHD medications were statistically associated with hypertension and arterial disease. Longer use, and higher doses posed the biggest risks. But the medications were not linked to arrhythmias, heart attacks, strokes, heart failure or other serious events with blood clots.
Numerous headlines claimed that the new evidence showed how dangerous ADHD medications are. Although the research has important public health implications, most patients should be reassured by the low risk to any particular individual. Only 4% of the participants had a newly diagnosed cardiovascular condition arise during the years of the study.
-----
Free link to my Medium Article on Stimulants and the Heart:
Follow on Medium for hundreds of full length articles on this subject and more!
Access to other Medium articles requires paid membership.
-----
References:
Attention-Deficit/Hyperactivity Disorder Medications and Long-Term Risk of Cardiovascular Diseases (2023)
Risk of Cardiovascular Diseases Associated With Medications Used in Attention-Deficit/Hyperactivity Disorder A Systematic Review and Meta-analysis (2022)
Long-term methylphenidate exposure and 24-hours blood pressure and left ventricular mass in adolescents and young adults with attention deficit hyperactivity disorder
Autonomic and endocrine control of cardiovascular function (2015)
Full Chapter list:
Streamed live January 31, 2024
-------------------------
Psychiatrist, neuroscientist, and author John Kruse, MD, PhD presents practical, actionable, well-researched information about treatment options that scientists and clinicians recommend for adult ADHD and other mental health conditions.
Subscribe if you're curious about how neuroatypical brains can optimize their functioning in our shared, and somewhat strange, world.
ADHD topics have a pink background, and those on more general mental health topics have a purple background. A small collection of Politics related videos have an orange background.
Dr. Kruse has posted videos in the "Videos", "Live", and "Shorts", sections of this channel.
You're welcome to email him with topics you want discussed or people you think he should interview.
drjohnkruse@gmail.com
#health #mentalhealth #adhd #stimulant #heart
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.